Lv3
348 积分 2023-07-04 加入
Targeting Regnase-1 in B7-H3-CAR T cells reprograms the tumor microenvironment and enhances antitumor efficacy for osteosarcoma
25天前
已完结
Intracranial delivery of B7-H3-targeting CAR-T cells for recurrent glioblastoma: a phase 1 trial
1个月前
已完结
Engineering a juxtamembrane-targeting CAR T-cell against mesothelin: a novel binder resilient to shed antigen for enhanced efficacy against ovarian and pancreatic cancer
1个月前
已完结
In vivo genome-wide CRISPR screens of human T cells in solid tumours
1个月前
已完结
CRISPR screens identify targets to rescue age-related T cell dysfunction in cancer
1个月前
已完结
De novo design of orthogonal far-red, orange, and green fluorophore-binding proteins for multiplexed imaging
2个月前
已完结
Dual-targeting LILRB3/LILRB4 CAR-T cells for the treatment of monocytic acute myeloid leukemia
2个月前
已完结
Non-Armored GCC-targeting CAR-T cell therapy demonstrates significant efficacy in patients with advanced colorectal cancer
2个月前
已完结
FDA-approved fulvestrant-induced CAR phase separation enables precise control of CAR T antitumor function
2个月前
已完结
Targeting UBE2F induces a resilience program enhancing CD8 T cell immunity
2个月前
已完结
皖公网安备34019202002308
